vs
Side-by-side financial comparison of Globalstar, Inc. (GSAT) and NATURES SUNSHINE PRODUCTS INC (NATR). Click either name above to swap in a different company.
NATURES SUNSHINE PRODUCTS INC is the larger business by last-quarter revenue ($123.8M vs $72.0M, roughly 1.7× Globalstar, Inc.). NATURES SUNSHINE PRODUCTS INC runs the higher net margin — 3.3% vs -16.1%, a 19.5% gap on every dollar of revenue. On growth, Globalstar, Inc. posted the faster year-over-year revenue change (17.6% vs 4.7%). Over the past eight quarters, Globalstar, Inc.'s revenue compounded faster (12.9% CAGR vs 5.6%).
Globalstar, Inc. is an American telecommunications company that operates a satellite constellation in low Earth orbit (LEO) for satellite phone, low-speed data transmission and Earth observation. The Globalstar second-generation constellation consists of 25 satellites.
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
GSAT vs NATR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $72.0M | $123.8M |
| Net Profit | $-11.6M | $4.1M |
| Gross Margin | — | 72.5% |
| Operating Margin | -0.5% | 4.3% |
| Net Margin | -16.1% | 3.3% |
| Revenue YoY | 17.6% | 4.7% |
| Net Profit YoY | 76.9% | 1379.4% |
| EPS (diluted) | $-0.11 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $72.0M | $123.8M | ||
| Q3 25 | $73.8M | $128.3M | ||
| Q2 25 | $67.1M | $114.8M | ||
| Q1 25 | $60.0M | $113.2M | ||
| Q4 24 | $61.2M | $118.2M | ||
| Q3 24 | $72.3M | $114.6M | ||
| Q2 24 | $60.4M | $110.6M | ||
| Q1 24 | $56.5M | $111.0M |
| Q4 25 | $-11.6M | $4.1M | ||
| Q3 25 | $1.1M | $5.3M | ||
| Q2 25 | $19.2M | $5.3M | ||
| Q1 25 | $-17.3M | $4.7M | ||
| Q4 24 | $-50.2M | $-321.0K | ||
| Q3 24 | $9.9M | $4.3M | ||
| Q2 24 | $-9.7M | $1.3M | ||
| Q1 24 | $-13.2M | $2.3M |
| Q4 25 | — | 72.5% | ||
| Q3 25 | — | 73.3% | ||
| Q2 25 | — | 71.7% | ||
| Q1 25 | — | 72.1% | ||
| Q4 24 | — | 72.0% | ||
| Q3 24 | — | 71.3% | ||
| Q2 24 | — | 71.4% | ||
| Q1 24 | — | 71.2% |
| Q4 25 | -0.5% | 4.3% | ||
| Q3 25 | 13.8% | 7.0% | ||
| Q2 25 | 9.2% | 3.7% | ||
| Q1 25 | -14.2% | 5.4% | ||
| Q4 24 | -6.9% | 3.8% | ||
| Q3 24 | 13.0% | 4.6% | ||
| Q2 24 | -2.4% | 5.1% | ||
| Q1 24 | -8.3% | 4.2% |
| Q4 25 | -16.1% | 3.3% | ||
| Q3 25 | 1.5% | 4.2% | ||
| Q2 25 | 28.6% | 4.6% | ||
| Q1 25 | -28.9% | 4.2% | ||
| Q4 24 | -82.1% | -0.3% | ||
| Q3 24 | 13.7% | 3.8% | ||
| Q2 24 | -16.0% | 1.2% | ||
| Q1 24 | -23.4% | 2.1% |
| Q4 25 | $-0.11 | $0.23 | ||
| Q3 25 | $-0.01 | $0.30 | ||
| Q2 25 | $0.13 | $0.28 | ||
| Q1 25 | $-0.16 | $0.25 | ||
| Q4 24 | $-0.57 | $-0.02 | ||
| Q3 24 | $0.00 | $0.23 | ||
| Q2 24 | $-0.01 | $0.07 | ||
| Q1 24 | $-0.01 | $0.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $447.5M | $93.9M |
| Total DebtLower is stronger | $483.8M | — |
| Stockholders' EquityBook value | $355.7M | $161.6M |
| Total Assets | $2.3B | $261.1M |
| Debt / EquityLower = less leverage | 1.36× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $447.5M | $93.9M | ||
| Q3 25 | $346.3M | $95.6M | ||
| Q2 25 | $308.2M | $81.3M | ||
| Q1 25 | $241.4M | $86.5M | ||
| Q4 24 | $391.2M | $84.7M | ||
| Q3 24 | $51.9M | $78.7M | ||
| Q2 24 | $64.3M | $68.7M | ||
| Q1 24 | $59.3M | $77.8M |
| Q4 25 | $483.8M | — | ||
| Q3 25 | $508.6M | — | ||
| Q2 25 | $491.5M | — | ||
| Q1 25 | $502.7M | — | ||
| Q4 24 | $511.4M | — | ||
| Q3 24 | $394.4M | — | ||
| Q2 24 | $393.1M | — | ||
| Q1 24 | $398.7M | $2.1M |
| Q4 25 | $355.7M | $161.6M | ||
| Q3 25 | $364.8M | $166.7M | ||
| Q2 25 | $360.9M | $163.7M | ||
| Q1 25 | $344.3M | $167.1M | ||
| Q4 24 | $358.9M | $161.0M | ||
| Q3 24 | $394.1M | $162.6M | ||
| Q2 24 | $383.0M | $156.4M | ||
| Q1 24 | $377.1M | $159.7M |
| Q4 25 | $2.3B | $261.1M | ||
| Q3 25 | $2.2B | $264.8M | ||
| Q2 25 | $1.9B | $254.9M | ||
| Q1 25 | $1.7B | $252.7M | ||
| Q4 24 | $1.7B | $240.9M | ||
| Q3 24 | $917.6M | $245.3M | ||
| Q2 24 | $926.2M | $235.8M | ||
| Q1 24 | $917.0M | $247.3M |
| Q4 25 | 1.36× | — | ||
| Q3 25 | 1.39× | — | ||
| Q2 25 | 1.36× | — | ||
| Q1 25 | 1.46× | — | ||
| Q4 24 | 1.43× | — | ||
| Q3 24 | 1.00× | — | ||
| Q2 24 | 1.03× | — | ||
| Q1 24 | 1.06× | 0.01× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $175.9M | $9.9M |
| Free Cash FlowOCF − Capex | — | $7.6M |
| FCF MarginFCF / Revenue | — | 6.1% |
| Capex IntensityCapex / Revenue | — | 1.9% |
| Cash ConversionOCF / Net Profit | — | 2.41× |
| TTM Free Cash FlowTrailing 4 quarters | — | $28.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $175.9M | $9.9M | ||
| Q3 25 | $236.0M | $18.5M | ||
| Q2 25 | $157.9M | $4.3M | ||
| Q1 25 | $51.9M | $2.6M | ||
| Q4 24 | $340.7M | $12.2M | ||
| Q3 24 | $32.0M | $9.6M | ||
| Q2 24 | $36.7M | $1.3M | ||
| Q1 24 | $29.8M | $2.2M |
| Q4 25 | — | $7.6M | ||
| Q3 25 | — | $16.8M | ||
| Q2 25 | — | $3.0M | ||
| Q1 25 | — | $1.5M | ||
| Q4 24 | — | $10.0M | ||
| Q3 24 | — | $7.9M | ||
| Q2 24 | — | $-2.0M | ||
| Q1 24 | — | $-1.5M |
| Q4 25 | — | 6.1% | ||
| Q3 25 | — | 13.1% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | 1.3% | ||
| Q4 24 | — | 8.5% | ||
| Q3 24 | — | 6.9% | ||
| Q2 24 | — | -1.9% | ||
| Q1 24 | — | -1.4% |
| Q4 25 | — | 1.9% | ||
| Q3 25 | — | 1.3% | ||
| Q2 25 | — | 1.2% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 1.5% | ||
| Q2 24 | — | 3.0% | ||
| Q1 24 | — | 3.3% |
| Q4 25 | — | 2.41× | ||
| Q3 25 | 216.53× | 3.46× | ||
| Q2 25 | 8.22× | 0.81× | ||
| Q1 25 | — | 0.55× | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.23× | 2.21× | ||
| Q2 24 | — | 0.97× | ||
| Q1 24 | — | 0.94× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GSAT
| Services | $67.4M | 94% |
| Products | $4.6M | 6% |
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
